HighTower Advisors’s Bristol-Myers Squibb BMY Stock Holding History

HighTower Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,600	Closed	-$16	–	3774
2024 Q4	$16	Sell	1,600 -1,000	-38%	-$55.9K	﹤0.01%	3792
2024 Q3	$4.07K	Buy	+2,600	New	+$122K	﹤0.01%	3603
2024 Q2	–	Sell	-200	Closed	-$531	–	3711
2024 Q1	$531	Buy	+200	New	+$10.2K	﹤0.01%	3543
2020 Q1	–	Sell	-3,000	Closed	-$14K	–	2237
2019 Q4	$14K	Buy	+3,000	New	+$172K	﹤0.01%	2186
2018 Q1	–	Sell	-15,000	Closed	-$2K	–	2205
2017 Q4	$2K	Buy	15,000 +2,100	+16%	+$131K	﹤0.01%	2231
2017 Q3	$50K	Buy	12,900 +8,400	+187%	+$490K	﹤0.01%	2084
2017 Q2	$13K	Buy	+4,500	New	+$245K	﹤0.01%	2099
2014 Q2	–	Sell	-2,000	Closed	-$4K	–	1605
2014 Q1	$4K	Buy	+2,000	New	+$106K	﹤0.01%	1541

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HighTower Advisors's BMY Position: Q2 2026 in Review

HighTower Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q2 2026, selling an estimated $1.53M and leaving 1,126,721 shares worth $64.9M. The position accounts for 0.06% of the portfolio, ranked #304.

HighTower Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $117M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

HighTower Advisors held 1,126,721 shares of Bristol-Myers Squibb worth $64.9M as of Q2 2026.
HighTower Advisors sold 26,606 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.53M.
Bristol-Myers Squibb made up 0.06% of HighTower Advisors's portfolio in Q2 2026, its #304 holding.
HighTower Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
HighTower Advisors's Bristol-Myers Squibb position peaked at $117M in Q2 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.